Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosisSteve Simpson, Ingrid van der Mei, Bruce Taylor et al.|Annals of Neurology|2010Cited by 453
Monthly Ambient Sunlight, Infections and Relapse Rates in Multiple SclerosisHelen Tremlett, Anne‐Louise Ponsonby, M. Núñez et al.|Neuroepidemiology|2008Cited by 157
Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosisFotini Pittas, Terry Dwyer, Anne‐Louise Ponsonby et al.|Journal of Neurology|2009Cited by 135
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MSNiall Stewart, Bruce Taylor, Steve Simpson et al.|Neurology|2012Cited by 96
Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing dosesHelen Tremlett, Anne‐Louise Ponsonby, Ingrid van der Mei et al.|Pharmacoepidemiology and Drug Safety|2008Cited by 78